Company Filing History:
Years Active: 2002-2006
Title: The Innovations of Bradley S Johnson
Introduction
Bradley S Johnson is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target inflammatory diseases. With a total of 2 patents, his work has the potential to impact the treatment of various health conditions.
Latest Patents
Johnson's latest patents focus on multicyclic compounds that inhibit leukocyte adhesion mediated by VLA-4. These compounds are designed to bind to VLA-4, effectively inhibiting leukocyte adhesion. This innovation is particularly useful in treating inflammatory diseases in mammals, including humans. Conditions such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis, and myocardial ischemia can benefit from these compounds. Additionally, they can be administered for the treatment of inflammatory brain diseases like multiple sclerosis.
Career Highlights
Bradley S Johnson is currently employed at Elan Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
Johnson collaborates with esteemed colleagues, including Francine S Grant and Michael A Pleiss, to further enhance the impact of his inventions.
Conclusion
Bradley S Johnson's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to addressing critical health issues. His work has the potential to change the landscape of treatment for various inflammatory diseases.